Esperion Therapeutics, Inc. · NASDAQ:ESPR
Fischer Seth H. Z. received 79,873 Esperion Therapeutics, Inc. shares as an award (Form 4)
Traded May 28, 2026 · Filed Jun 1, 2026
On May 28, 2026, Fischer Seth H. Z. (Director) received 79,873 Esperion Therapeutics, Inc. shares as an award, leaving 141,023 shares. Filed Jun 1, 2026 (Form 4).
- Awarded
- 79,873 shares
- Holding after
- 141,023 shares
- Trading plan
- No
- Role
- Director
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| May 28, 2026 | Common Stock | Award | 79,873 | 141,023 | Direct |
Source
Related
- Esperion Therapeutics, Inc.
- Fischer Seth H. Z.
- Esperion Therapeutics, Inc. shareholders
- Form 4 · Fischer Seth H. Z. · Jul 13, 2026
- Schedule 13G · Goldman Sachs Group Inc · Aug 13, 2026
- Schedule 13G · Vanguard Capital Management LLC · Jul 31, 2026
- Schedule 13G/A · Wasatch Advisors LP · Jul 14, 2026
- Form 4 · Hoffman Robert E. · Jul 13, 2026
- Form 4 · Carroll J Martin · Jul 13, 2026